第五章 綜合討論
第五節 研究限制與未來發展
國
立 政 治 大 學
‧
N a tio na
l C h engchi U ni ve rs it y
67
但 Morin 的安眠藥物依賴性失眠的循環現象，可能較關注開始持續服用助眠 藥物的歷程，並未對長期服用助眠藥物後，個案對助眠藥物的態度進行詮釋。其 他研究也較少比較助眠藥物使用者間的不同用藥心態。然而，本研究發現，相同 的助眠藥物使用型態，其用藥心態可能有差異，單一的循環模式可能較無法涵蓋 多種助眠藥物使用型態。本研究可以提供助眠藥物使用型態的更多現象描述。
第五節 研究限制與未來發展
本研究是採橫斷面的研究取向，收集助眠藥物使用者當下的用藥型態與相關 量表。此種研究取向，無法以縱貫研究的方式了解一個助眠藥物使用者的歷程變 化，因此雖能將助眠藥物使用型態分群，但卻難以觀察到使用者的動態歷程變化。
也無法了解，不同的用藥型態，是否能預測個案之後的用藥行為，因此，若想探 討此現象，仍待後續的研究對不同類型的助眠藥物使用者進行追蹤，去評估是否 不同用藥型態會影響個案的助眠藥物使用。
另外，本研究因樣本較小，並未將樣本拆半，進行一部分進行模型建立以及 模型預測，若想要驗證此預測模型是否能類化到大樣本，則待後續收集更多的使 用者，進行預測分類，以更確立本研究的預測變項信、效度。
此外，臨床現象發現有一群個案，會濫用助眠藥物，到各醫療院所索取藥 物，或是在黑市進行交易，雖然比例不高，但已有許多個案報告指出此現象確 實存在。然而，本研究在醫院以及社區收案時，較少招募到這群個案，若想瞭 解這群個案的使用型態，則後續研究可以針對此類型個案進行召募。
最後，由於研究題目，以及招募沒有服用過助眠藥物或沒有失眠情形的個 案填寫此份有問卷有其難度也不符合研究目的，故本研究所招募的參與者，在 特質上本身就為較相近的群體，因此雖然可以看出不同的用藥型態，但在睡眠 脆弱特質或相關心理變項的差異可能較少，故建議往後的研究，可將這群個案 的樣本特性與常模進行比較。
‧ 國
立 政 治 大 學
‧
N a tio na
l C h engchi U ni ve rs it y
68
參考文獻
沈武典（2001）。醫療院所 Benzodiazpine 藥物不當使用的初步分析。行政院衛生 署管制藥品管理局九十年度委託科技研究計畫報告。台北市：台北醫學院。
李澄賢（2003）。大學生情緒調節、調節焦點、樂觀與創造力之關係。未出版之 碩士論文，國立政治大學，台北市。
初麗娟、高尚仁（2005）。壓力知覺對負面心理健康影響：靜坐經驗、情緒智能 調 節 效 果 之 探 討 The Moderation of Meditation Experience and Emotional Intelligence on the Relationship between Perceived Stress and Negative Mental Health。中華心理學刊，2（47），157-179。
車先蕙、盧孟良、陳錫中、張尚文、李宇宙（2006）。中文版貝克焦慮量表之信 效度。台灣醫學，4（10），447-454。
林一真（2000）。貝克焦慮量表（BAI：1993年版）中文版。台北市：中國行為科 學社。
林詩淳 (2008)。慢性失眠者與情境性失眠高危險族群之壓力因應與失眠的關係。
未出版之碩士論文，國立政治大學，台北市。
林雅筑（2004）。安眠鎮靜劑之使用評估及失眠患者用藥指導之研究。未出版之 碩士論文，國立成功大學，台南市。
林晏瑄（2011）。 睡眠脆弱特質對認知激發狀態下的睡眠中訊息處理之影響。未 出版之碩士論文，國立政治大學，台北市。
吳佳璇（2005）。台灣鎮靜安眠類藥品使用盛行率以及相關後遺症之研究。行政 院衛生署管制藥品管理局。
洪嘉璣（2003）。藥物濫用者之渴想心理歷程:以強制戒治者為例。未出版之碩士
論文，國立台灣大學，台北市。
苯二氮平類（Benzodiazepines）藥品用於鎮靜安眠之使用指引（2007）
許文耀（2009）。海洛因藥癮者的抑制控制探討。台北市，政治大學。國科會計 畫。
陳心怡（2000）。貝克憂鬱量表第二版（BDI-II）中文版。台北市：中國行為科學 社。
陳昌偉（2014）。安眠藥物長期使用型態之探討。未出版之博士論文，國立政治 大學，台北市。
陳昌偉、詹雅雯、楊建銘、林詩淳（2009）。中文版睡眠失功能信念及態度量表 之信效度探討。Dysfunctional Beliefs and Attitudes about Sleep（DBAS）:
Validation of the Chinese Version，臨床心理學刊，1（4），59-67。
傅雅懌（2009）。海洛因藥癮者的抑制歷程初探。碩士，國立中正大學，嘉義縣。
楊建銘、許世杰、林詩淳、周映妤、陳瑩明(2009)。失眠嚴重度量表中文版的信、
效度研究。臨床心理學刊，2（4），95-104。
‧
behavior in patients with major depression. Journal of Clinical Psychiatry,58(6), 249-251Ajzen, I. (1991). The theory of planned behavior. Organizational behavior and human decision processes, 50(2), 179-211.
Ajzen, I., & Fishbein, M. (1980). Understanding attitudes and predicting social behaviour. Englewood Cliffs, NJ: Prentice-Hall.
An, H., & Chung, S. (2012). The influence of personality and dysfunctional sleep-related cognitions on the severity of insomnia. Psychiatry research,197(3), 275-279.
Ancoli-Israel, S., Richardson, G.S., Mangano, R.M., Jenkins, L., Hall, P., & Jones, W.S.
(2005). Long-term use of sedative hypnotics in older patients with insomnia. Sleep Medicine, 6(2), 107-113.
Ansseau, M., Pitchot, W., Hansenne, M., & Moreno, A. (1992). Psychotic reactions to zolpidem. The Lancet, 339(8796), 809.
Asplund, R. (2000). Sleep and hypnotic use in relation to perceived somatic and mental health among the elderly. Archives of Gerontology and Geriatrics, 31(3), 199-205.
Ashton, H. (1994). Guidelines for the rational use of benzodiazepines. Drugs,48(1), 25-40.
Baglioni, C., Spiegelhalder, K., Lombardo, C., & Riemann, D. (2010). Sleep and emotions: a focus on insomnia. Sleep medicine reviews, 14(4), 227-238.
Baillargeon, L., Landreville, P., Verreault, R., Beauchemin, J. P., Grégoire, J. P., &
Morin, C. M. (2003). Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering:
a randomized trial. Canadian Medical Association Journal, 169(10), 1015-1020.
Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004). Cognitive effects of long-term benzodiazepine use. CNS Drugs, 18(1), 37-48.
Bastien, C. H., Vallières, A., & Morin, C. M. (2004). Precipitating factors of insomnia. Behavioral sleep medicine, 2(1), 50-62.
Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the Insomnia
‧
Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297-307.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: psychometric properties. Journal of consulting and clinical psychology, 56(6), 893.Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996).
Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. Journal of personality assessment, 67(3), 588-597.
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory. San Antonio, TX: Psychological Corporation.
Belleville, G., & Morin, C. M. (2008). Hypnotic discontinuation in chronic insomnia:
Impact of psychological distress, readiness to change, and self-efficacy. Health Psychology, 27(2), 239-248.
Bélanger, L., Belleville, G., & Morin, C. (2009). Management of hypnotic discontinuation in chronic insomnia. Sleep medicine clinics, 4(4), 583.
Bélanger, L., Vallières, A., Ivers, H., Moreau, V., Lavigne, G., & Morin, C. M. (2007).
Meta ‐ analysis of sleep changes in control groups of insomnia treatment trials. Journal of sleep research, 16(1), 77-84.
Benca, R. M. (2005). Diagnosis and treatment of chronic insomnia: a review.
Psychiatric services, 56(3), 332-343.
Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward:
hedonic impact, reward learning, or incentive salience?. Brain Research Reviews, 28(3), 309-369.
Bonnet, M. H., & Arand, D. L. (1995). 24-Hour metabolic rate in insomniacs and matched normal sleepers. sleep-, 18(7), 581-581.
Bonnet, M. H., & Arand, D. L. (1996). The consequences of a week of insomnia.
sleep, 19(6), 453-461.
Bonnet, M. H., & Arand, D. L. (1997). Hyperarousal and insomnia. Sleep Medicine Reviews, 1(2), 97-108.
Busto, U. E., Ruiz, I., Busto, M., & Gacitua, A. (1996). Benzodiazepine use in Chile:
impact of availability on use, abuse, and dependence. Journal of clinical psychopharmacology, 16(5), 363-372.
Busto, U., & Sellers, E. M. (1991). Pharmacologic aspects of benzodiazepine tolerance and dependence. Journal of substance abuse treatment, 8(1), 29-33.
Busto, U. E., Ruiz, I., Busto, M., & Gacitua, A. (1996). Benzodiazepine use in Chile:
impact of availability on use, abuse, and dependence. Journal of clinical psychopharmacology, 16(5), 363-372.
Carney, C. E., & Edinger, J. D. (2006). Identifying critical beliefs about sleep in primary insomnia. Sleep, 29(4), 444-453.
‧
Charney, D. S., Mihic, S. J., & Harris, R. A. (2001). Hypnotics and sedatives. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 399-327.
Chen, W. J., Chen, H. M., Chen, C. C., Chen, C. C., Yu, W. Y., & Cheng, A. T. A. (2002).
Cloninger's Tridimensional Personality Questionnaire: psychometric properties and construct validity in Taiwanese adults. Comprehensive Psychiatry, 43(2), 158-166.
Clift, A. D. (1972). Factors leading to dependence on hypnotic drugs. Br Med J, 3(5827), 614-617.
Cloninger, C. R. (1985). A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments, 4(3), 167-226.
Cloninger, C. R. (1987). A systematic method for clinical description and classification of personality variants: a proposal. Archives of General Psychiatry, 44(6), 573-588.
Cloninger, C. R., Przybeck, T. R., & Svrakic, D. M. (1991). The tridimensional personality questionnaire: US normative data. Psychological reports, 69(3), 1047-1057.
Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24(4), 385-396.
Cricco, M., Simonsick, E. M., & Foley, D. J. (2001). The impact of insomnia on cognitive functioning in older adults. Journal of the American Geriatrics Society, 49(9), 1185-1189.
Cumming, R. G., & Le Conteur, D. G. (2003). Benzodiazepines and risk of hip fractures in older people. CNS drugs, 17(11), 825-837.
de las Cuevas, C., Sanz, E., & de la Fuente, J. (2003). Benzodiazepines: more"
behavioural" addiction than dependence. Psychopharmacology, 167(3), 297-303.
Drake, C., Richardson, G., Roehrs, T., Scofield, H., & Roth, T. (2004). Vulnerability to stress-related sleep disturbance and hyperarousal. Sleep, 27(2), 285-292.
Dooley, M., & Plosker, G. L. (2000). Zaleplon: a review of its use in the treatment of insomnia. Drugs, 60(2), 413-445.Estivill, E. (2002). Behaviour of insomniacs and implication for their management. Sleep medicine reviews, 6, S3-S6.
Fang, S. Y., Chen, C. Y., Chang, I., Wu, E. C. H., Chang, C. M., & Lin, K. M. (2009).
Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug and Alcohol Dependence, 104(1), 140-146.
Fishbein, M., & Ajzen, I. (1975). Belief, attitude, intention and behavior: An introduction to theory and research. Reading, MA: Addison-Wesley.
Freedman, R. R., & Sattler, H. L. (1982). Physiological and psychological factors in sleep-onset insomnia. Journal of Abnormal Psychology, 91(5), 380.
Gallagher, P. F., Barry, P. J., Ryan, C., Hartigan, I., & O'Mahony, D. (2008).
‧
Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age and ageing, 37(1), 96-101.
Godin, G., & Kok, G. (1996). The theory of planned behavior: a review of its applications to health-related behaviors. American journal of health promotion,11(2), 87-98.
Gorgels, W., Oude Voshaar, R. C., Mol, A. J. J., Van De Lisdonk, E. H., Van Balkom, A., Breteler, M. H. M., . . . Zitman, F. G. (2006). Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice. Family Practice, 23(1), 65-72.
Griffiths, R. R., & Weerts, E. M. (1997). Benzodiazepine self-administration in humans and laboratory animals–implications for problems of long-term use and abuse. Psychopharmacology, 134(1), 1-37.
Grimm, J. W., Hope, B. T., Wise, R. A., & Shaham, Y. (2001). Neuroadaptation:
incubation of cocaine craving after withdrawal. Nature, 412(6843), 141-142.
Gross, J. J., & John, O. P. (2003). Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being.Journal of personality and social psychology, 85(2), 348.
Hall-Porter, J. M., Schweitzer, P. K., Eisenstein, R. D., Ahmed, H. A., & Walsh, J. K.
(2014). The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation. Journal of clinical sleep medicine: JCSM:
official publication of the American Academy of Sleep Medicine, 10(1), 27-34.
Hajak, G., Müller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. (2003). Abuse and dependence potential for the non ‐ benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction, 98(10), 1371-1378.
Harvey, A. G. (2002). A cognitive model of insomnia. Behaviour research and therapy, 40(8), 869-893.
Hastie, T., Tibshirani, R., Friedman, J., Hastie, T., Friedman, J., & Tibshirani, R.
(2009). The elements of statistical learning (Vol. 2, No. 1). New York: Springer.
Healey, S. E., Kales, A., Monroe, L. J., Bixler, E. O., Chamberlin, K., & Soldatos, C.
R. (1981). Onset of Insomnia: Role of Life-Stress Events.Psychosomatic Medicine, 43(5), 439-451.
Herings, R. M., Stricker, B. H. C., de Boer, A., Bakker, A., & Sturmans, F. (1995).
Benzodiazepines and the risk of falling leading to femur fractures: dosage more important than elimination half-life. Archives of Internal Medicine,155(16), 1801-1807.
Hofmann, M., & Eichhorn, M. (1998). Unsatisfied craving: zolpidem (Stilnox) dependence syndrome. Psychiatrische Praxis, 25(6), 313.
‧
Holbrook, A. M., Crowther, R., Lotter, A., Cheng, C., & King, D. (2000). Meta-analysis of benzodiazepine use in the treatment of insomnia. Canadian Medical Association Journal, 162(2), 225-233.
Hoyler, C. L., Tekell, J. L., & Silva, J. A. (1996). Zolpidem-induced agitation and disorganization. General hospital psychiatry, 18(6), 452-453.
Huedo-Medina, T. B., Kirsch, I., Middlemass, J., Klonizakis, M., & Siriwardena, A. N.
(2012). Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ: British Medical Journal, 345.
Isacson, D. (1997). Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time—a 13-year follow-up in a Swedish community. Social science & medicine, 44(12), 1871-1880.
Ishigooka,, J., Sugiyama,, T., Suzuki, M., Kobayashi, K., Takeuchi, H., & Murasaki, M.
(1998). Survival analytic approach to long‐term prescription of benzodiazepine hypnotics. Psychiatry and clinical neurosciences, 52(5), 541-545.
Jorm, A. F., Grayson, D., Creasey, H., Waite, L., & Broe, G. A. (2000). Long‐term benzodiazepine use by elderly people living in the community. Australian and New Zealand Journal of Public Health, 24(1), 7-10.
Kao, C. C., Huang, C. J., Wang, M. Y., & Tsai, P. S. (2008). Insomnia: prevalence and its impact on excessive daytime sleepiness and psychological well-being in the adult Taiwanese population. Qual Life Res, 17(8), 1073-1080. doi:
10.1007/s11136-008-9383-9
Kassam, A., & Patten, S. B. (2006). Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians. Population health metrics,4(1), 15.
Kirkwood, C. K. (1998). Management of insomnia. Journal of the American Pharmaceutical Association (Washington, DC: 1996), 39(5), 688-96.
Krakow, B., Ulibarri, V. A., & Romero, E. (2010). Persistent insomnia in chronic hypnotic users presenting to a sleep medical center: A retrospective chart review of 137 consecutive patients. The Journal of Nervous and Mental Disease, 198(10), 734-741.
Krystal, A. D., Walsh, J. K., Laska, E., Caron, J., Amato, D. A., Wessel, T. C., & Roth, T. (2003). Sustained efficacy of eszopiclone over 6 months of nightly treatment:
results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. SLEEP-NEW YORK THEN WESTCHESTER-,26(7), 793-800.
Lader, M. (1994). Benzodiazepines. CNS Drugs, 1(5), 377-387.
Lader, M., & Russell, J. (1993). Guidelines for the prevention and treatment of benzodiazepine dependence: Summary of a report from the Mental Health Foundation. Addiction.88, 1707-1708
‧
Moride, Y. (2002). Benzodiazepine use and risk of dementia: A nested case–control study. Journal of clinical epidemiology, 55(3), 314-318.
Landi, F., Onder, G., Cesari, M., Barillaro, C., Russo, A., & Bernabei, R. (2005).
Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 60(5), 622-626.
Leahy, R. L. (2002). A model of emotional schemas. Cognitive and Behavioral Practice, 9(3), 177-190.
LeBlanc, M., Beaulieu-Bonneau, S., Mérette, C., Savard, J., Ivers, H., & Morin, C. M.
(2007). Psychological and health-related quality of life factors associated with insomnia in a population-based sample. Journal of Psychosomatic Research, 63(2), 157-166.
Liappas, I. A., Malitas, P. N., Dimopoulos, N. P., Gitsa, O. E., Liappas, A. I., Nikolaou, C. K., & Christodoulou, G. N. (2003). Zolpidem dependence case series: possible neurobiological mechanisms and clinical management. Journal of psychopharmacology, 17(1), 131-135.
Lichstein, K. L., Nau, S. D., Wilson, N. M., Aguillard, R. N., Lester, K. W., Bush, A. J.,
& McCrae, C. S. (2013). Psychological treatment of hypnotic-dependent insomnia in a primarily older adult sample. Behaviour research and therapy,51(12), 787-796.
Linden, M., Bär, T., & Geiselmann, B. (1998). Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions.Psychological medicine, 28(03), 721-729.
Lord, S. R., Anstey, K. J., Williams, P. H. I. L. I. P. P. A., & Ward, J. A. (1995).
Psychoactive medication use, sensori ‐ motor function and falls in older women.British journal of clinical pharmacology, 39(3), 227-234.
Love, A., James, D., & Willner, P. (1998). A comparison of two alcohol craving questionnaires. Addiction, 93(7), 1091-1102.
Maczaj, M. (1993). Pharmacological treatment of insomnia. Drugs, 45(1), 44-55.
Mellinger, G. D., Balter, M. B., & Uhlenhuth, E. H. (1985). Insomnia and its treatment:
prevalence and correlates. Archives of general psychiatry, 42(3), 225-232.
Mendelson(2011). Pharmacology. In: Meir, H.K., Roth, T., William, C.,(ends), Principles and practice of sleep medicine 5th ed (483-491). St Louis, MO: Elsevier Merica, H., Blois, R., & Gaillard, J. M. (1998). Spectral characteristics of sleep EEG in
chronic insomnia. European Journal of Neuroscience, 10(5), 1826-1834.
Miller, S. M. (1979). Controllability and human stress: Method, evidence and theory.
Behaviour Research and Therapy, 17(4), 287-304.
Minowa, M., Okawa, M., & Uchiyama, M. (2000). Prevalence of sleep disturbance and
‧
hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population. Journal of epidemiology/Japan Epidemiological Association, 10(2), 79-86.
Morgan, K., Dallosso, H., Ebrahim, S., Arie, T., & Fentem, P. H. (1988). Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home.
British Medical Journal, 296(6622), 601-602.
Morgenthaler, T. I., & Silber, M. H. (2002). Amnestic sleep-related eating disorder associated with zolpidem. Sleep Medicine, 3(4), 323-327.
Morin, C. M. (1993). Insomnia: Psychological assessment and management(pp. 46-60).
D. H. Barlow (Ed.). New York: Guilford Press.
Morin, C. M., Bastien, C. H., Guay, B., Radouco-Thomas, M., Leblanc, J., & Vallieres, A. (2004). Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. American Journal of Psychiatry, 161(2), 332-342.
Morin, C. M., Bélanger, L., & Bernier, F. (2004). Correlates of benzodiazepine use in individuals with insomnia. Sleep medicine, 5(5), 457-462.
Morin, C. M., Bélanger, L., Bastien, C. H., & Vallières, A. (2005). Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. Behaviour Research and Therapy, 43(1), 1-14.
Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999). Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. Jama, 281(11), 991-999.
Morin, C. M., Culbert, J. P., & Schwartz, S. M. (1994). Nonpharmacological interventions for insomnia. Am J Psychiatry, 151(8), 1172-1180.
Morin, C. M., LeBlanc, M., Daley, M., Gregoire, J. P., & Merette, C. (2006).
Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med, 7(2), 123-130.
Morin, C. M., Stone, J., Trinkle, D., Mecer, J., & Remsberg, S. (1993). Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia
Morin, C. M., Stone, J., Trinkle, D., Mecer, J., & Remsberg, S. (1993). Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia